AstraZeneca to collaborate with UPenn on Alzheimer’s disease

Tuesday 23 March 2010

AstraZeneca Plc has concluded a collaborative research agreement with the University of Pennsylvania in the US to generate new drug candidates for Alzheimer’s disease. Financial details were not disclosed.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom